Toggle Navigation

Gizmodo report features the TelAbortion study

An article featuring Gynuity’s TelAbortion study has been posted to the online media platform, Gizmodo, and is available to download here.

Gynuity’s innovative study evaluates the use of telemedicine for providing a medical abortion to women who may have difficulty getting to a clinic. Through the study, women receive medications by mail and are followed by their providers remotely. Women living in Hawaii, Oregon, Washington and Maine are currently eligible to participate.

For more information about this study, please visit TelAbortion.org

Gynuity & FIGO organize panel on postpartum hemorrhage management at ACOG 2018 Congress

American College of Obstetricians & Gynecologists (ACOG) Annual Clinical and Scientific Meeting 2018

April 27 – 30, 2018│Austin Convention Center │ Austin, Texas

Rethinking Postpartum Hemorrhage Management: The Role of Simple Technologies in Expanding Access to Postpartum Hemorrhage Management

April 28, 2018 │ 9:00 – 9:50am │ Room 18AB

Moderator: Paul D Blumenthal, Stanford University Medical Center

  • Beyond blood loss: Role of shock index in PPH diagnosis. Jill Durocher, Gynuity Health Projects
  • New evidence on the potential role of the simple low cost drugs misoprostol and tranexamic acid (TXA) in expanding PPH management. Beverly Winikoff, Gynuity Health Projects
  • New insights and evidence from a multi-country study on use of condom uterine balloon tamponade in PPH management. Gillian Burkhardt, Gynuity Health Projects

Presentations will be followed by a brief Q & A. Presenters will also be available after the session to demonstrate assembly of the condom-catheter uterine balloon.

The International Federation of Gynecology and Obstetrics (FIGO) is a UK-based organization that brings together professional societies of obstetricians and gynecologists from around the world. Its vision is for women to achieve the highest possible standards of physical, mental, reproductive and sexual health and wellbeing throughout their lives.

Gynuity Health Projects is a US-based research and technical assistance organization which works globally to ensure that reproductive and maternal health technologies are widely available at reasonable cost, provided in the context of high-quality services, and offered in a way that recognizes the dignity and autonomy of each individual. 

Further details about the ACOG Annual Meeting 2018 can be found here.

Gynuity Health Project’s E-news bulletin

Gynuity Health Project's E-news bulletin shares information about the work of our staff and collaborators in the field. We report on recent and upcoming meetings, highlights of new and ongoing projects, recently published articles and materials, and some of our key achievements. We will also have a "Spotlight on..." feature in each newsletter providing an in-depth look at a specific project.

Click here to view our May 2017 E-news bulletin
Click here to view our September 2017 E-news bulletin
Click here to view our December 2017 E-news bulletin

NAF annual meeting

At the 2018 National Abortion Federation (NAF) annual meeting, Ilana Dzuba (Gynuity) and Mariana Romero (NAF & CEDES) organized and moderated the Jorge Villarreal International Plenary, "Legal Abortion for the First Time in 28 Years: Translating Law into High-Quality Services", to highlight issues around access to legal abortion care in Chile following the decriminalization of abortion in specific circumstances in 2017. Panelists included:

Dr. Carolina Asela, formerly of the Chilean Ministry of Health
Dr. Gonzalo Rubio Schweitzer, Hospital San José/Universidad de Santiago de Chile
Débora Solís Martínez, (APROFA)
Carolina Posada (IPPF/WHR)

In addition, Gynuity's Senior Medical Associate, Elizabeth Raymond, gave presentations on Gynuity's TelAbortion project:

Presentation: “Telemedicine abortion: The U.S. experience,” by Elizabeth Raymond, as part of the panel “Telemedicine and Medical Abortion,” during the Canadian Providers Meeting

Presentation: “A direct-to-patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 months,” by Elizabeth Raymond, Scientific Papers session

Presentation: “The TelAbortion Study,” by Elizabeth Raymond, as part of the panel “Building bridges, not walls: Ensuring access to abortion through innovation and collaboration”

And the following posters were presented by Gynuity staff:

Poster: Paving the way for pharmacy distribution: Assessing whether women undergoing medical abortion can independently use and interpret the results of multi-level pregnancy tests
Louie, K., Platais, I., Tsereteli, T., Tsertsvadze, G., Gabaidze, T., Vardanyan, S., Abrahamyan, R., Grigoryan, G., Grebennikova, G., Chong, E.

Poster: Incorporating multi-level pregnancy tests into a telemedicine abortion service to improve women’s assessments of abortion outcomes
Chong, E., Sheldon, W.R., Lopez-Green, D., Gulías Ogando, M., Hernandez, B., Blum, J.

Poster: Is there a role for medical menstrual regulation in the U.S.? Assessing potential interest among women in New Jersey and Michigan
Sheldon, W.R., Tarnagada, M., Talmont, E., Harris, L.H., Starr, K.A., Winikoff, B.

Poster: A survey study exploring FDA REMS-related barriers to the provision of medical abortion
Louie, K., Chong, E., Raymond, E., Winikoff, B.

Gynuity staff present on postpartum hemorrhage diagnosis & management at upcoming EBCOG Congress

26th European Board & College of Obstetrics and Gynaecology (EBCOG) Congress
March 8-10, 2018 │ Palais des Congrès de Paris │ Paris, France

New Evidence and Innovations in PPH Diagnosis and Management
Friday, March 9, 2018 | 13:45 – 15:15 | Bordeaux Amphitheater

FIGO and Gynuity Health Projects invite you to join us for a scientific session that includes presentations of new evidence on PPH diagnosis and management followed by a Q&A. 
Session Chair: Prof Sir Sabaratnam Arulkumaran, past RCOG and FIGO president

Time to rethink how we diagnose and treat PPH? The role of shock index
Beverly Winikoff, President, Gynuity Health Projects

Expanding options for PPH management at all levels of care: The role of misoprostol and condom uterine balloon tamponade
Rasha Dabash, Senior Director, Gynuity Health Projects

Adding tranexamic acid (TXA) to the arsenal of interventions: The WOMAN trial results
Haleema Shakur-Still, Associate Professor, LSHTM

Full details about the EBCOG congress can be found here.